Table 1 Microorganisms evaluated for susceptibility-resistance to antibiotics that inhibit peptidoglycan synthesis
Gram | Bacteria | Antibiotics- CLSI MIC Interpretative Standard (μg/mL) | CLSI Category | MIC (μg/ml) | Drug concentration at which the nucleoids were spread - and DNA fragments were released |
|---|---|---|---|---|---|
Gram - | Acinetobacter baumannii | Imipenem: ≤ 4 - 8 - ≥16 (SI, R) | Susceptible | 2 | 4-4 |
Gram - | Acinetobacter baumannii | Imipenem: ≤ 4 - 8 - ≥16 (SI, R) | Intermediate | 8 | 16-16 |
Gram - | Acinetobacter baumannii | Imipenem: ≤ 4 - 8 - ≥16 (SI, R) | Resistant | > 16 | No nucleoids-No fragments |
Gram - | Acinetobacter baumannii | Imipenem: ≤ 4 - 8 - ≥16 (SI, R) | Resistant | > 16 | No nucleoids-No fragments |
Gram - | Acinetobacter baumannii | Ceftazidime: ≤ 8 - 16 - ≥32 (S, I, R) | Susceptible | 4 | 8-8 |
Gram - | Acinetobacter baumannii | Ceftazidime: ≤ 8 - 16 - ≥32 (S, I, R) | Intermediate | 12 | 32-32 |
Gram - | Acinetobacter baumannii | Ceftazidime: ≤ 8 - 16 - ≥32 (S, I, R) | Resistant | > 256 | No nucleoids-No fragments |
Gram - | Enterobacter cloacae | Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) | Susceptible | < 1 | 1-1 |
Gram - | Enterobacter cloacae | Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) | Susceptible | < 1 | 1-1 |
Gram - | Enterobacter cloacae | Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) | Susceptible | < 1 | 4-4 |
Gram - | Enterobacter cloacae | Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) | Susceptible | < 1 | 4-4 |
Gram - | Escherichia coli | Ampicillin: ≤ 8 - 16- ≥32 (S, I, R) | Susceptible | 2 | 8-8 |
Gram - | Escherichia coli | Ampicillin: ≤ 8 - 16- ≥32 (S, I, R) | Intermediate | 12 | 16-16 |
Gram - | Escherichia coli | Ampicillin: ≤ 8 - 16- ≥32 (S, I, R) | Resistant | 256 | No nucleoids-No fragments |
Gram - | Escherichia coli | Ceftazidime: ≤ 4 -8- ≥16 (S, I, R) | Susceptible | 0.25 | 4-4 |
Gram - | Escherichia coli | Ceftazidime: ≤ 4 -8- ≥16 (S, I, R) | Resistant | 32 | No nucleoids-No fragments |
Gram - | Klebsiella oxytoca | Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) | Susceptible | < 1 | 1-1 |
Gram - | Klebsiella oxytoca | Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) | Susceptible | < 1 | 4-4 |
Gram - | Klebsiella spp. | Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) | Susceptible | < 1 | 1-1 |
Gram - | Klebsiella spp. | Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) | Susceptible | < 1 | 1-1 |
Gram - | Klebsiella spp. | Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) | Susceptible | < 1 | 1-1 |
Gram - | Klebsiella spp. | Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) | Intermediate | 8 | 16-16 |
Gram - | Klebsiella spp. | Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) | Resistant | > 16 | No nucleoids-No fragments |
Gram - | Klebsiella spp. | Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) | Resistant | > 16 | No nucleoids-No fragments |
Gram - | Morganella morganii | Imipenem: ≤ 1 - 2 -≥4 (S, I, R) | Intermediate | 2 | 4-4 |
Gram - | Morganella morganii | Ceftazidime: ≤ 4 - 8 -≥16 (S, I, R) | Susceptible | < 1 | 4-4 |
Gram - | Proteus mirabilis | Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) | Intermediate | 2 | 4-4 |
Gram - | Proteus mirabilis | Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) | Susceptible | < 1 | 4-4 |
Gram - | Salmonella spp | Imipenem: ≤ 1 - 2 - ≥4 (S, I, R) | Susceptible | < 1 | 1-1 |
Gram - | Salmonella spp | Ceftazidime: ≤ 4 - 8 - ≥16 (S, I, R) | Susceptible | < 1 | 4-4 |
Gram+ | Enterococcus faecalis | Ampicillin: ≤ 8 - ≥16 (S, R) | Susceptible | 4 | 8-No fragments |
Gram+ | Enterococcus faecalis | Penicillin: ≤ 8 - ≥16 (S, R) | Susceptible | 2 | 8-No fragments |
Gram+ | Enterococcus faecalis | Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) | Resistant | > 32 | No nucleoids-No fragments |
Gram+ | Enterococcus faecium | Ampicillin: ≤ 8 - ≥16 (S, R) | Resistant | > 32 | No nucleoids-No fragments |
Gram+ | Enterococcus faecium | Penicillin: ≤ 8 - ≥16 (S, R) | Resistant | > 32 | No nucleoids-No fragments |
Gram+ | Enterococcus faecium | Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) | Susceptible | < 1 | 4-No fragments |
Gram+ | Enterococcus spp. | Ampicillin: ≤ 8 - ≥16 (S, R) | Susceptible | < 1 | 8-No fragments |
Gram+ | Enterococcus spp. | Ampicillin: ≤ 8 - ≥16 (S, R) | Intermediate | 12 | 16-No fragments |
Gram+ | Enterococcus spp. | Ampicillin: ≤ 8 - ≥16 (S, R) | Resistant | > 16 | No nucleoids-No fragments |
Gram+ | Enterococcus spp. | Penicillin: ≤ 8 - ≥16 (S, R) | Susceptible | 2 | 8-No fragments |
Gram+ | Enterococcus spp. | Penicillin: ≤ 8 - ≥16 (S, R) | Resistant | > 16 | No nucleoids-No fragments |
Gram+ | Enterococcus spp. | Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) | Susceptible | 2 | 4-No fragments |
Gram+ | Enterococcus spp. | Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) | Resistant | > 32 | No nucleoids-No fragments |
Gram+ | Enterococcus spp. | Vancomycin: ≤ 4 -8/16- ≥32 (S, I, R) | Resistant | > 32 | No nucleoids-No fragments |
Gram+ | Staphylococcus aureus | Vancomycin: ≤2 - 4-8 - ≥16 (S, I, R) | Susceptible | < 1 | 2-No fragments |
Gram+ | Staphylococcus aureus | Vancomycin: ≤2 - 4-8 - ≥16 (S, I, R) | Susceptible | < 1 | 2-No fragments |